Healthcare Private Equity Market 2024: Year in Review and Outlook

Deal activity, large-cap concentration and the themes that will define healthcare PE through 2026.

After a cautious 2023, healthcare private equity returned with selective conviction. Large deals clustered in provider platforms and specialty pharmacy, while add-on volume stayed healthy. We review how the number of large deals influenced multiples, and where we expect dry powder to move next: home health, revenue-cycle tech, and services around GLP-1 care pathways.